SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.86−3.09 (-17.21%)
Close on Nov 19, 2026Market cap $3.00BP/E –Yield –
SELLAS Life Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
SELLAS Life Sciences's free cash flow for the twelve months ending Dec 31, 2016 was -$11.86M. For fiscal 2016 it was -$11.86M. The highest annual figure on record is -$10.36M in fiscal 2010.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | -$11.86M | – |
| FY2015 | Dec 31, 2015 | -$48.31M | – |
| FY2014 | Dec 31, 2014 | -$42.93M | – |
| FY2013 | Dec 31, 2013 | -$29.25M | – |
| FY2011 | Dec 31, 2011 | -$14.72M | – |
| FY2010 | Dec 31, 2010 | -$10.36M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016 | Dec 31, 2016 | $25.07M | – |
| Q3 FY2016 | Sep 30, 2016 | -$12.21M | – |
See a number that looks wrong?